Abstract: A method for compliance with Know Your Customer (KYC) and other regulations includes a pseudonymous globally unique identifier stored on a blockchain that associates a pseudonymous first party address with a globally unique identifier representing the vetted identity of the owner of the address. The method also includes a trusted third party issuing a verifiable credential for a first pseudonymous party to a proposed transaction to a second pseudonymous party to the transaction.

Abstract: A Dynamic Random Access Memory (DRAM) controller. The DRAM controller includes receiving a plurality of access requests from a plurality of user interfaces to access one or more DRAM devices. Further, the DRAM controller includes storing the plurality of access requests in a Content Addressable Memory (CAM). Furthermore, the DRAM controller includes updating at least one access request of the plurality of access requests to a Next Access Table. In addition, the DRAM controller includes determining at least one paramount access request of the plurality of access requests by a CAM based decision controller for employing a bypass operation in the CAM based decision controller, based on a plurality of pre-defined conditions. Further, the DRAM controller includes issuing the plurality of access requests to the one or more DRAM devices.

Abstract: A method and system for accessing a dynamic random access memory (DRAM) is provided. A memory controller includes a content addressable memory (CAM) based decision control module for determining a next best access request for the DRAM. The CAM based decision control module includes a CAM access storage module for storing access requests, a next access table module for storing the next best access request, and a decision logic module for determining the next best access request based on results from the CAM access storage module and the next access table module. Further, the memory controller includes a DRAM access control interface for implementing signaling required to access the DRAM. The method includes storing access requests in a CAM access storage module. The method includes determining which of the stored access requests is a next best access request. Further, the method includes processing the next best access request.

Abstract: A method of controlling a dynamic random access memory (DRAM) and a DRAM memory controller is provided. An example DRAM memory controller includes a content addressable memory (CAM) based decision control module. The CAM based decision control module includes a CAM access storage module, a next access table module, and a decision logic module. Further, the DRAM memory controller includes a DRAM access control interface. The method includes detecting a request for a read-modify-write operation. The method also includes creating a read access request and a write access request based on the detecting. Further, the method includes prioritizing the read access request and the write access request. Moreover, the method includes executing the read access request and the write access request based on the prioritizing.

Abstract: An efficient implementation of a digital delay locked loop (DLL) circuit is disclosed. The delay locked loop (DLL) circuit includes a phase detector circuit, a clock divider circuit, a delay, a delay control finite state machine (FSM) and an output low pass filter. The delay includes a coarse delay line and a fine delay line. The coarse delay line delays a signal by a fixed large amount and the fine delay line introduces a smaller precise delay. The delay control FSM adjusts the delay to keep the output signal of the DLL synchronized with the input. The adjustment is averaged over a range of cycle periods in order to avoid adjusting the edges of signal waveform constantly. The low pass filter at the output minimizes the jitter in the output signal.

Abstract: The present invention is directed to vaginal tablets comprising misoprostol and a pharmaceutically acceptable pH insensitive, hydrophilic cellulose material, wherein the vaginal tablets do not contain a hydrophobic release controlling agent, and wherein the misoprostol and the pharmaceutically acceptable pH insensitive, hydrophilic cellulose material are in a ratio of about 1:50 to about 1:800, and wherein the vaginal tablets do not substantially change the pH of a vaginal tract.

Abstract: The present invention relates to novel formulations of methotrexate in liquid form that are suitable for oral use.